Avid bioservices, inc. and crb highlight efforts that enabled opening of first phase of new viral vector facility in california in only eight months

53,000-square-foot facility addresses unique demands of commercial-scale viral vector production costa mesa, calif. , june 16, 2022 /prnewswire/ -- avid bioservices, inc. (nasdaq:cdmo), a dedicated contract development and manufacturing organization (cdmo) focused on development and cgmp manufacturing services for biotechnology and pharmaceutical companies, today highlighted the companies' collaborative efforts that enabled the phase-one opening of its new purpose-built, 53,000-square-foot viral vector and cgmp facility in costa mesa, california, in only eight months.
CDMO Ratings Summary
CDMO Quant Ranking